TITLE

Characterization of Bacterial Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients Who Received Prophylactic Levofloxacin With Either Penicillin or Doxycycline

AUTHOR(S)
THERRIAULT, BRIDGETTE L.; WILSON, JOHN W.; BARRETO, JASON N.; ESTES, LYNN L.
PUB. DATE
August 2010
SOURCE
Mayo Clinic Proceedings;Aug2010, Vol. 85 Issue 8, p711
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To describe the effect of a combination prophylactic regimen of levofloxacin, a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class, with either penicillin or doxycycline on the changing epidemiology of bacterial infections and antimicrobial resistance patterns of Isolated organisms in the allogeneic hematopoletic stem cell transplant (HSCT) patient population. PATIENTS AND METHODS: We conducted a single-center, retrospective cohort study of all allogeneic HSCT recipients from January 1, 2003, through August 31, 2008, who received prophylactic levofloxacin In combination with penicillin (or with doxycycline in penicillin-allergic patients) from allogeneic stem cell Infusion until neutrophil engraftment. RESULTS: Of the 258 patients who underwent allogeneic HSCT during the study period, 231 received levofioxacin prophylaxis, 76 (33%) of whom developed an Infection within 3 months after transplant. Over time, the ratio of gram-positive to gram-negative (GN) Infections decreased from 2.11 in 2004, the first year that GN organisms were isolated, to 1.11 in 2008 (P=20). Emergence of fluoroquinolone-resistant GN bacteria was observed (P=.02), whereas resistance to extended-spectrum β-lactams did not change over time. Combined vancomycin-resistant enterococci colonization and Infection rates increased during the study period (P=.04). Clostridium difficile colitis was uncommon. CONCLUSION: Levofloxacin with penicillin or doxycycline prophylaxis may contribute to the emergence of resistant GN infections in allogeneic HSCT recipients overtime. Our findings provide additional support for the current standard of practice of administering empiric monotherapy with an antipseudomonal β-lactam if these patients develop fever or are suspected to have an infection.
ACCESSION #
52889929

 

Related Articles

  • MafB is an inducer of monocytic differentiation. Kelly, Louise M.; Englmeier, Ursula; Lafon, Isabelle; Sieweke, Michael H.; Graf, Thomas // EMBO Journal;5/1/2000, Vol. 19 Issue 9, p1987 

    The bZip transcription factor MafB is expressed specifically in the myeloid lineage of the hematopoietic system and is up-regulated successively during myeloid differentiation from multipotent progenitors to macrophages. Here we report that this induction reflects an essential role of MafB in...

  • Hematopoiesis leading to a diversity of dendritic antigen-presenting cell types. Petvises, Sawang; O'Neill, Helen C // Immunology & Cell Biology;Apr2012, Vol. 90 Issue 4, p372 

    Hematopoietic stem cells (HSCs) undergo expansion and differentiation, giving rise to all terminally differentiated blood cells throughout life. HSCs are found in distinct anatomical sites during development, and in adults, hematopoiesis occurs predominantly on the luminal side of the bone...

  • Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Orkin, Stuart H.; Zon, Leonard I. // Nature Immunology;Apr2002, Vol. 3 Issue 4, p323 

    Hematopoietic stem cells (HSCs) provide for blood formation throughout the life of the individual. Studies of HSCs form a conceptual framework for the analysis of stem cells of other organ systems. We review here the origin of HSCs during embryological development, the relationship between...

  • A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Bhatia, Mickie; Bonnet, Dominique; Murdoch, Barbara; Gan, Olga I.; Dick, John E. // Nature Medicine;Sep98, Vol. 4 Issue 9, p1038 

    The detection of primitive hematopoietic cells based on repopulation of immune-deficient mice is a powerful tool to characterize the human stem-cell compartment. Here, we identify a newly discovered human repopulating cell, distinct from previously identified repopulating cells, that initiates...

  • Generation of HSCs in the embryo and assays to detect them. Yoder, Mervin C. // Oncogene;9/20/2004 Review, Vol. 23 Issue 43, p7161 

    The precise temporal and spatial emergence of hematopoietic stem cells (HSC) in the murine embryo has been somewhat controversial largely due to differences in the assays utilized to demonstrate HSC repopulating ability. One strategy is to determine where and when one can first detect HSC that...

  • The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. Kurokawa, Mineo; Mitani, Kinuko; Yamagata, Tetsuya; Takahashi, Tokiharu; Izutsu, Koji; Ogawa, Seishi; Moriguchi, Tetsuo; Nishida, Eisuke; Yazaki, Yoshio; Hirai, Hisamaru // EMBO Journal;6/15/2000, Vol. 19 Issue 12, p2958 

    Evi-1 encodes a nuclear protein involved in leukemic transformation of hematopoietic cells. Evi-1 possesses two sets of zinc finger motifs separated into two domains, and its characteristics as a transcriptional regulator have been described. Here we show that Evi-1 acts as an inhibitor of c-Jun...

  • Hematopoietic developmental pathways: on cellular basis. Iwasaki, H.; Akashi, K. // Oncogene;10/15/2007, Vol. 26 Issue 47, p6687 

    To elucidate the molecular mechanisms underlying normal and malignant hematopoietic development, it is critical to identify developmental intermediates for each lineage downstream of hematopoietic stem cells. Recent advances in prospective isolation of hematopoietic stem and progenitor cells,...

  • Regulating the high self-renewal phenotype in fetal haemopoietic stem cells.  // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jul2007, Vol. 15 Issue 1, p67 

    The article discusses a study on differences in the higher speed of renewal between fetal hemopoietic stem cells (HSC) and adult HSC. Such difference is due to modulation by developmentally regulated intrinsic switch and involves the activation of a multiple lineage-specific differentiation...

  • Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Cancelas, Jose A.; Lee, Andrew W.; Prabhakar, Rethinasamy; Stringer, Keith F.; Yi Zheng; Williams, David A. // Nature Medicine;Aug2005, Vol. 11 Issue 8, p886 

    The molecular events that regulate engraftment and mobilization of hematopoietic stem cells and progenitors (HSC/Ps) are still incompletely defined. We have examined the role of the Rho GTPases Rac1 and Rac2 in HSC engraftment and mobilization. Rac1, but not the hematopoietic-specific Rac2, is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics